Interestingly, HVS did not affect the EGF-mediated scattering in prostate cancer cells, confirming that this oleocanthal-based derivative significantly impaired tumor cell motility and invasiveness mediated only by the HGF/c-Met axis and eliminated the possibility of off-target effects (Figure 5C). Here, MET is linked to prostate carcinoma.